Grant Chamberlain

Non Executive Director at Clinical Genomics

Grant Chamberlain has been working in the financial industry since 1998. Grant began their career at Deutsche Bank as a Managing Director. In 2010, they moved to Nomura where they served as Managing Director, Head of Mergers & Acquisitions Australia. In 2013, they joined Merrill Lynch and held two roles, Managing Director, Head of Mergers & Acquisitions and Financial Sponsors, and Managing Director, Head of Mergers & Acquisitions Australia. In 2017, they became a Non Executive Director at Immutep and a Partner and Principal at OneVentures. In 2018, they were appointed Non Executive Director at Smart Sparrow. In 2019, they were named Non Executive Director at KEYPAY CLOUD PAYROLL & WORKFORCE MANAGEMENT. In 2020, they became Non Executive Director at SourseAI and in 2021 they were appointed Non Executive Director at Clinical Genomics and Lumary.

Grant Chamberlain attended the University of Melbourne from 1990 to 1994, where they obtained a Bachelor of Laws (Hons) and a Bachelor of Commerce. Grant'sfield of study was Law and Commerce.

Location

Sydney, Australia

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Clinical Genomics

1 followers

Clinical Genomics is a privately held biotechnology company developing products for colorectal cancer diagnosis and recurrence monitoring.


Industries

Employees

51-200

Links